Gast ::
| Hauptseite > Publikationsdatenbank > Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma > print |
| Hauptseite > Publikationsdatenbank > Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma > print |
| 001 | 862532 | ||
| 005 | 20210130001436.0 | ||
| 024 | 7 | _ | |a 10.1186/s13014-019-1272-6 |2 doi |
| 024 | 7 | _ | |a 2128/22143 |2 Handle |
| 024 | 7 | _ | |a pmid:31036031 |2 pmid |
| 024 | 7 | _ | |a WOS:000466926300003 |2 WOS |
| 024 | 7 | _ | |a altmetric:59926054 |2 altmetric |
| 037 | _ | _ | |a FZJ-2019-02831 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Katsigiannis, Sotirios |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
| 245 | _ | _ | |a Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma |
| 260 | _ | _ | |a London |c 2019 |b BioMed Central |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1556777049_31943 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Background and purposeTo evaluate the effect of timing of radiotherapy (RT) on survival in patients with newly diagnosed primary glioblastoma (GBM) treated with the same therapeutical protocol.Materials and methodsPatients with newly diagnosed primary GBM treated with the same therapeutical scheme between 2010 and 2015 in our institution were retrospectively reviewed. The population was trichotomized based on the time interval from surgery till initiation of RT (< 28 days, 28–33 days, > 33 days). Kaplan-Meier and Cox regression analyses were used to compare progression free survival (PFS) and overall survival (OS) between the groups. The influence of various extensively studied prognostic factors on survival was assessed by multivariate analysis.ResultsOne-hundred-fifty-one patients met the inclusion criteria. Between the three groups no significant difference in PFS (p = 0.516) or OS (p = 0.902) could be demonstrated. Residual tumor volume (RTV) and midline structures involvement were identified as independent prognostic factors of PFS while age, O-6-Methylguanine Methyltransferase (MGMT) status, Ki67 index, RTV and midline structures involvement represented independent predictors of OS. Patients starting RT after a prolonged delay (> 48 days) exhibited a significantly shorter OS (p = 0.034). |
| 536 | _ | _ | |a 572 - (Dys-)function and Plasticity (POF3-572) |0 G:(DE-HGF)POF3-572 |c POF3-572 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef |
| 700 | 1 | _ | |a Krischek, Boris |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Barleanu, Stefanie |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Grau, Stefan |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Galldiks, Norbert |0 P:(DE-Juel1)143792 |b 4 |u fzj |
| 700 | 1 | _ | |a Timmer, Marco |0 P:(DE-HGF)0 |b 5 |
| 700 | 1 | _ | |a Kabbasch, Christoph |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Goldbrunner, Roland |0 P:(DE-HGF)0 |b 7 |
| 700 | 1 | _ | |a Stavrinou, Pantelis |0 P:(DE-HGF)0 |b 8 |
| 773 | _ | _ | |a 10.1186/s13014-019-1272-6 |g Vol. 14, no. 1, p. 73 |0 PERI:(DE-600)2224965-5 |n 1 |p 73 |t Radiation oncology |v 14 |y 2019 |x 1748-717X |
| 856 | 4 | _ | |y OpenAccess |u https://juser.fz-juelich.de/record/862532/files/s13014-019-1272-6.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://juser.fz-juelich.de/record/862532/files/s13014-019-1272-6.pdf?subformat=pdfa |
| 909 | C | O | |o oai:juser.fz-juelich.de:862532 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 4 |6 P:(DE-Juel1)143792 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-572 |2 G:(DE-HGF)POF3-500 |v (Dys-)function and Plasticity |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
| 914 | 1 | _ | |y 2019 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-3-20090406 |k INM-3 |l Kognitive Neurowissenschaften |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-Juel1)INM-3-20090406 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|